Evidence map›Paper›PMID 29602847›Full record

ArticleBMJ open2018

Protocol for the mixed-methods process and context evaluation of the

Melanie Boeckmann, Iveta Nohavova, Omara Dogar, Eva Kralikova, Alexandra Pankova, Kamila Zvolska, Rumana Huque, Razia Fatima, Maryam Noor, Helen Elsey and 4 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Nicotine receptor partial agonists for smoking cessation.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 5 countries.

Melanie BoeckmannInstitute of General Practice, Addiction Research and Clinical Epidemiology Unit, Medical Faculty of the Heinrich-Heine-University, Düsseldorf, Germany.ORCID 0000-0001-5909-5508
Iveta NohavovaUniversity Hospital Prague VFN v. PRAZE, Prague, Czech Republic.
Omara DogarDepartment of Health Sciences, University of York, York, UK.
Eva KralikovaUniversity Hospital Prague VFN v. PRAZE, Prague, Czech Republic.
Alexandra PankovaUniversity Hospital Prague VFN v. PRAZE, Prague, Czech Republic.
Kamila ZvolskaUniversity Hospital Prague VFN v. PRAZE, Prague, Czech Republic.
Rumana HuqueARK Foundation, Dhaka, Bangladesh.
Razia FatimaNational Tuberculosis Control Programme (NTP), Islamabad, Pakistan.
Maryam NoorThe Initiative, Islamabad, Pakistan.
Helen ElseyLeeds Institute of Health Sciences, University of Leeds, Leeds, UK.
Aziz SheikhUsher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
Kamran SiddiqiDepartment of Health Sciences, University of York, York, UK.
Daniel KotzInstitute of General Practice, Addiction Research and Clinical Epidemiology Unit, Medical Faculty of the Heinrich-Heine-University, Düsseldorf, Germany.
TB & Tobacco Project Consortium
General University Hospital in Prague · CZUniversity of York · GBARK Foundation · BDHeinrich Heine University Düsseldorf · DEMaastricht University · NLUniversity of Edinburgh · GBUniversity of Leeds · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTuberculosis (TB) remains a significant public health problem in South Asia. Tobacco use increases the risks of TB infection and TB progression. The METHODS AND ANALYSIS: We are conducting a mixed-methods process and context evaluation informed by an intervention logic model that draws on the UK Medical Research Council's Process Evaluation Guidance. Our approach includes quantitative and qualitative data collection on context, recruitment, reach, dose delivered, dose received and fidelity. Quantitative data include patient characteristics, reach of recruitment among eligible patients, routine trial data on dose delivered and dose received, and a COM-B ('capability', 'opportunity', 'motivation' and 'behaviour') questionnaire filled in by participating health workers. Qualitative data include semistructured interviews with TB health workers and patients, and with policy-makers at district and central levels in each country. Interviews will be analysed using the framework approach. The behavioural intervention delivery is audio recorded and assessed using a predefined fidelity coding index based on behavioural change technique taxonomy. ETHICS AND DISSEMINATION: The study complies with the guidelines of the Declaration of Helsinki. Ethics approval for the study and process evaluation was granted by the University of Leeds (qualitative components), University of York (trial data and fidelity assessment), Bangladesh Medical Research Council and Bangladesh Drug Administration (trial data and qualitative components) and Pakistan Medical Research Council (trial data and qualitative components). Results of this research will be disseminated through reports to stakeholders and peer-reviewed publications and conference presentations. TRIAL REGISTRATION NUMBER: ISRCTN43811467; Pre-results.

Indexed as

SmokingTuberculosisAdultBangladeshHumansPakistanRandomized Controlled Trials as TopicResearch DesignTobacco Productsclinical trialsepidemiologyorganisation of health servicespublic healthqualitative researchtuberculosis

Identifiers

PMID29602847
PMCPMC5887198
OpenAlexW2795070470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.